Literature DB >> 10563611

Aberrant expression of cyclin-dependent kinase 5 in inclusion body myositis.

S Nakano1, I Akiguchi, S Nakamura, H Satoi, S Kawashima, J Kimura.   

Abstract

OBJECTIVE: To investigate abnormal protein expression in inclusion body myositis (IBM).
BACKGROUND: In IBM, ectopic deposition of beta-amyloid protein as well as several other proteins in some muscle fibers occurs. Some, but not all, of these proteins are also expressed in myofibrillar myopathy (MFM). The authors recently reported aberrant expressions of several cyclin-dependent kinases (CDKs)-enzymes regulating the cell replication cycle-in MFM. They therefore tested the notion that aberrant expression of CDKs also occurs in IBM. Among CDKs, CDK1, CDK2, and CDK5 have been demonstrated to phosphorylate tau, which is a component of inclusions in IBM. CDK5 appears in a stage of myogenesis when CDK1 and CDK2 are downregulated.
METHODS: Cryostat sections of muscle specimens from 10 patients with sporadic IBM were immunostained for CDK1, CDK2, and CDK5. Fourteen patients with polymyositis and eight individuals with dermatomyositis served as disease control subjects.
RESULTS: In IBM, numerous CDK5-positive inclusions were present in vacuolated fibers. CDK5 expression was not observed in any disease control subject. Regenerating fibers expressed CDK1 and CDK2 in all diseases.
CONCLUSION: The results suggest that cyclin-dependent kinases (CDK)5, but no other CDKs, is involved in the formation of inclusions in IBM.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10563611     DOI: 10.1212/wnl.53.8.1671

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  6 in total

1.  Foxo/atrogin induction in human and experimental myositis.

Authors:  Han-Kyu Lee; Edward Rocnik; Qinghao Fu; Bumsup Kwon; Ling Zeng; Kenneth Walsh; Henry Querfurth
Journal:  Neurobiol Dis       Date:  2012-05       Impact factor: 5.996

2.  Genetically augmenting Abeta42 levels in skeletal muscle exacerbates inclusion body myositis-like pathology and motor deficits in transgenic mice.

Authors:  Masashi Kitazawa; Kim N Green; Antonella Caccamo; Frank M LaFerla
Journal:  Am J Pathol       Date:  2006-06       Impact factor: 4.307

3.  Investigation of splicing changes and post-translational processing of LMNA in sporadic inclusion body myositis.

Authors:  Yue-Bei Luo; Chalermchai Mitrpant; Russell Johnsen; Vicki Fabian; Merrilee Needham; Sue Fletcher; Steve D Wilton; Frank L Mastaglia
Journal:  Int J Clin Exp Pathol       Date:  2013-08-15

4.  Casein kinase 1 alpha associates with the tau-bearing lesions of inclusion body myositis.

Authors:  Theresa J Kannanayakal; Jerry R Mendell; Jeff Kuret
Journal:  Neurosci Lett       Date:  2007-12-15       Impact factor: 3.046

5.  Molecular markers for granulovacuolar degeneration are present in rimmed vacuoles.

Authors:  Masahiro Nakamori; Tetsuya Takahashi; Tomokazu Nishikawa; Yu Yamazaki; Takashi Kurashige; Hirofumi Maruyama; Koji Arihiro; Masayasu Matsumoto
Journal:  PLoS One       Date:  2013-11-28       Impact factor: 3.240

6.  How citation distortions create unfounded authority: analysis of a citation network.

Authors:  Steven A Greenberg
Journal:  BMJ       Date:  2009-07-20
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.